Dr. Blaney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6620 Fannin; 1570.40
Texas Children's Hospital
Houston, TX 77030Phone+1 832-822-1482- Is this information wrong?
Summary
- Dr. Susan Blaney holds the David G. Poplack, M.D. Chair of Pediatric Hematology-Oncology at Texas Children's Hospital and the Elise C. Young Chair of Pediatric Oncology at Baylor College of Medicine. She is also the Director of Texas Children's Cancer and Hematology Center and Division Chief of Pediatric Hematology/Oncology for Baylor College of Medicine. She was the Vice Chair of the Children's Oncology Group (COG) from 2013-2020.
Previously, Dr. Blaney served in various roles at Baylor College of Medicine, including Vice President for Clinical and Translational Research, Executive Vice Chair of the Department of Pediatrics, and founding director of the Dan L. Duncan Institute for Clinical and Translational Research (ICTR), among others.
Her career, spanning over 25 years, is dedicated to improving therapeutic strategies for children with recurrent or refractory cancer, especially malignancies of the central nervous system. She has participated in the development of numerous clinical trials of novel agents for the treatment of childhood cancer.
Dr. Blaney has been a mentor to many in the field of pediatric oncology and has served on various advisory and membership roles, including the NCI’s Clinical Trial Advisory and Investigational Drug Steering Committees, FDA’s Pediatric Oncology Drug Advisory Committee, and more.
She has received numerous awards and has published over 200 articles in peer-reviewed journals. She also co-edits Rudolph’s Pediatrics and Pizzo and Poplack’s Pediatric Oncology.
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1987 - 1990
- Letterman Army Medical CenterResidency, Pediatrics, 1985 - 1987
- Tripler Army Medical CenterInternship, Transitional Year, 1984 - 1985
- The University of Toledo College of MedicineClass of 1984
Certifications & Licensure
- TX State Medical License 1995 - 2025
- MD State Medical License 1988 - 1992
- CA State Medical License 1986 - 1988
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Medical Honoree American Cancer Society; Houston, TX, 2023
- The David G. Poplack MD Chair in Pediatric Oncology Texas Children's Hospital, 2021
- Women of Excellence Award Baylor College of Medicine, 2019
- Join now to see all
Clinical Trials
- Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment Start of enrollment: 2000 Apr 01
- Bortezomib in Treating Children With Advanced Solid Tumors Start of enrollment: 2001 Nov 01
- Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors Start of enrollment: 2002 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsPhase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report.Jack Su, Lindsay Kilburn, David B Mansur, Mark Krailo, Allen Buxton, Adesina Adekunle, Amar Gajjar, Peter C Adamson, Brenda J. Weigel, Elizabeth Fox, Susan M. Blaney, ...> ;Neuro-Oncology. 2021 Aug 4
- Editorial: Recent Advances in Pediatric OncologySusan M. Blaney> ;Current Opinion in Pediatrics. 2019 Feb 1
- 5 citationsRecent advances in pediatric oncology.Susan M. Blaney> ;Current Opinion in Pediatrics. 2017 Nov 1
- Join now to see all
Journal Articles
- A phase 1 trial of cixutumumab (IMC-A12) in combination with temsirolimus (CCI-779) in children with recurrent solid tumors: a Children’s Oncology Group Phase 1 Consor...Fouladi, M., Perentesis, J.P., Wagner, L.M., Vinks, A.A., Reid, J., Ingle, A.M., Thomas, G., Krueger, D.A., Houston, P., Doyle, L.A., Weigel, B., Blaney, S.M., Clin Cancer Research, 1/1/2014
- Phase 1 trial of Seneca Valley virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children’s Oncology GroupBurke, M.J., Ahern, C., Weigel, B.J., Poirier, J.T., Rudin, C., Chen, Y., Cripe, R., Bernhardt, M.B., Blaney, S.M., Ped Blood and Cancer, 1/1/2014
- A phase 1 trial and pharmacokinetic study of the raf kinase and receptor tyrosine kinase inhibitor, sorafenib, in children with refractory solid tumors or refractory l...Widemann, B.C., Kim, A., Fox, E., Baruchel, S., Adamson, P.C., Ingle, A.M., Bender, J.G., Burke, M., Weigel, B., Stempak, D., Balis, F.M., Blaney, S.M., Clin Cancer Res, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A phase 1 study of cabozantinib (XL184) in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: a Children’s Oncology Group Phase ...Chuk, M., Widemann, B., Ahern, C., Reid, J., Fox, E., Weigel, B., Blaney, S.M., ASCO, 1/1/2014
- A phase II study of cixutumumab in combination with temsirolimus in pediatric patients with recurrent or refractory solid tumors: a report from the Children’s Oncology...Wagner, L.M., Fouladi, M., Ahmed, A., Krailo, M.D., Weigel, B., DuBois, S., Doyle, L.A., Chen, H., Blaney, S.M., ASCO, 1/1/2014
- A phase 2 study of the c-Met inhibitor, tivantinib (ARQ 197, IND#112603) in children with relapsed or refractory solid tumors: a Children’s Oncology Group study.Geller, J.I., Perentesis, J.P., Ahern, C.H., Reid, J.M., Fox, E., Blaney, S.M., Weigel, B.J., ASCO, 1/1/2014
- Join now to see all
Lectures
- Introduction to Pediatric CNS TumorsTexas Children’s Cancer Center, Baylor College of Medicine, Houston, TX - 1/1/2014
- Oncologic EmergenciesTexas Children’s Hospital, Houston, TX - 1/1/2014
- Introduction to ChemotherapyTexas Children’s Hospital, Houston, TX - 1/1/2014
- Join now to see all
Press Mentions
- Dr. Michael Taylor Joins Texas Children’s Hospital and Baylor College of Medicine as Director of the Pediatric Neuro-Oncology Research ProgramFebruary 8th, 2023
- Film Available on YouTube Shines Light on Childhood CancerSeptember 10th, 2020
- Grand Opening Set for Halo House’s 33-Unit Facility for Cancer PatientsMay 2nd, 2019
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Texas Children's HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: